27.02.2024 22:11:58 - dpa-AFX: Myriad Genetics Inc. Q4 Earnings Summary

WASHINGTON (dpa-AFX) - Below are the earnings highlights for Myriad Genetics
Inc. (MYGN):

Earnings: -$31.2 million in Q4 vs. -$42.3 million in the same period last year.
EPS: -$0.36 in Q4 vs. -$0.52 in the same period last year.
Excluding items, Myriad Genetics Inc. reported adjusted earnings of $3.5 million
or $0.04 per share for the period.

Analysts projected $0.01 per share
Revenue: $196.6 million in Q4 vs. $177.8 million in the same period last year.


Copyright(c) 2024 RTTNews.com. All Rights Reserved

Copyright RTT News/dpa-AFX
Name WKN Börse Kurs Datum/Zeit Diff. Diff. % Geld Brief Erster Schluss
Myriad Genetics 897518 NASDAQ 22,670 05.06.24 21:54:13 +0,330 +1,48% 22,660 22,680 22,510 22,340

© 2000-2024 DZ BANK AG. Bitte beachten Sie die Nutzungsbedingungen | Impressum
2024 Infront Financial Technology GmbH